Cardiovascular events in chronic dialysis patients: Emphasizing the importance of vascular disease prevention

20Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cardiovascular disease is the leading cause of death in both chronic kidney disease and peritoneal dialysis/hemodialysis patients. Vascular disease prevention in these patients is therefore important to reduce the incidence of cardiovascular events and the high morbidity and mortality. This Editorial discusses the traditional, (1) smoking, (2) dyslipidemia, (3) body mass index, (4) glycemic control and (5) blood pressure, and non-traditional, (1) anemia, (2) vitamin D/hyperparathyroidism, (3) calcium/phosphorus metabolism and (4) magnesium, risk factors in renal patients. Current evidence does not support routine statin use and antiplatelet medication to dialysis patients. Patient compliance and adherence to proposed measures could be essential to reduce cardiovascular events and mortality rates in this high-risk population. © 2010 Springer Science+Business Media, B.V.

Cite

CITATION STYLE

APA

Paraskevas, K. I., Kotsikoris, I., Koupidis, S. A., Tzovaras, A. A., & Mikhailidis, D. P. (2010). Cardiovascular events in chronic dialysis patients: Emphasizing the importance of vascular disease prevention. International Urology and Nephrology, 42(4), 999–1006. https://doi.org/10.1007/s11255-010-9795-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free